Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
about
Aripiprazole partial agonism at 5-HT2C: a comparison of weight gain associated with aripiprazole adjunctive to antidepressants with high versus low serotonergic activitiesSerotonin as a New Therapeutic Target for Diabetes Mellitus and ObesityGenetics of Common Antipsychotic-Induced Adverse EffectsTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsBioinformatic analyses to select phenotype affecting polymorphisms in HTR2C gene.Pharmacogenetics of antipsychotics.Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care.Pharmacogenetics and antipsychotics: therapeutic efficacy and side effects predictionPersonalized medicine in psychiatry: problems and promises.Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain.Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies.Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment.Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review.Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications.Pharmacogenetics of response to antipsychotics in patients with schizophrenia.Toward understanding genetic risk for differential antipsychotic response in individuals with schizophrenia.Pharmacogenetics in schizophrenia: a review of clozapine studies.Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.Pharmacogenetics of second-generation antipsychotics.HTR2C polymorphisms, olanzapine-induced weight gain and antipsychotic-induced metabolic syndrome in schizophrenia patients: a meta-analysis.Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis.Development of CNS multi-receptor ligands: Modification of known D2 pharmacophoresWeight gain changes in patients with aripiprazole monotherapy compared with aripiprazole-antidepressant polypharmacy in an outpatient sample.Functional consequences of two HTR2C polymorphisms associated with antipsychotic-induced weight gain.Synthesis and evaluation of the structural elements in alkylated tetrahydroisoquinolines for binding to CNS receptors.Antipsychotic-induced weight gain: can the energy balance gene variants help us tip the scales?Genetic variants impacting metabolic outcomes among people on clozapine: a systematic review and meta-analysis.Associations between the -2548G/A Promoter and Baseline Weight and between Gln223Arg and Lys656Asn Variants and Change in BMI Scores in Arab Children and Adolescents Treated with Risperidone
P2860
Q24615556-F63895FB-A098-4F4B-91E7-E91E70389220Q26749092-D855F120-C7C3-4FF6-9807-B288AC51A3F2Q28072893-3DD82EA1-298B-43BF-89B3-92F78393AB3BQ28079065-A450BFB4-FB3C-44DB-B9B0-A2AF4CAEE9A1Q30404381-F9A71D5C-5EBC-49AB-A280-19BEAB589518Q33836837-E92277D9-E580-4968-968A-88CD27A21509Q34623350-4E49FAB6-C9AD-4D6B-AA1B-C03032860C3AQ34676533-F8373AFA-8B14-4162-B3A8-D4A9B898FF19Q34726454-F6E6D3AB-3DCC-477F-A213-3288F35BD5D8Q36441507-DE9A71E0-D753-4401-B509-BA1D4440BB00Q36956632-7C44F6EB-3DA3-47A3-8356-0CB63920D8CDQ37220366-8AD469D8-B5CF-44C5-9EE4-968BEED9761BQ37719385-0CA3BC55-972F-4816-9CF8-04FCA647245EQ37917782-F6C33C02-8660-4C31-AA09-17150D95EA00Q37926893-C078FF3D-6DBF-4604-BE8D-384E87A18AAFQ37952823-84F96D1B-C535-4F75-BDF7-626FD74D0B7CQ37960512-CB0F7577-247F-4936-9E6D-1354A8489A9BQ38154175-AFCECE17-758B-4552-9B3D-AB91547C8D01Q38154911-264F7F77-AC9F-495F-ACAE-A031BC2A253FQ38217628-41938C4C-CE4C-4F58-893D-E75286435156Q38242739-5C6A4879-37EF-4D6C-B0C2-B0A176B29360Q38842714-4BD98AD5-10C7-4404-8567-7D80EA866EAFQ40626733-E11F4869-9742-4CB1-B6B6-9D3BA06BF8D9Q46133710-AB5DBDDA-B2EC-4812-9633-E4AB04DED235Q46356344-51F559EB-B0F3-4C77-8BA1-0BF5FF69B183Q47160314-C2DB204E-D2CF-4481-846B-99AEA5547390Q47178969-60B1BD1A-7A42-4B9E-A003-6B5BA4FCDA2EQ47628101-7658495A-C4CF-485B-B336-67440D5DE885Q58598653-42456FF6-95FE-4AFB-910D-E9C645C1F2BA
P2860
Association of HTR2C, but not LEP or INSIG2, genes with antipsychotic-induced weight gain in a German sample.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Association of HTR2C, but not ...... eight gain in a German sample.
@en
Association of HTR2C, but not ...... eight gain in a German sample.
@nl
type
label
Association of HTR2C, but not ...... eight gain in a German sample.
@en
Association of HTR2C, but not ...... eight gain in a German sample.
@nl
prefLabel
Association of HTR2C, but not ...... eight gain in a German sample.
@en
Association of HTR2C, but not ...... eight gain in a German sample.
@nl
P2093
P2860
P356
P1433
P1476
Association of HTR2C, but not ...... weight gain in a German sample
@en
P2093
Arun K Tiwari
Carolin Opgen-Rhein
Daniel J Müller
Eva Janina Brandl
Michael Dettling
Thomas Sander
P2860
P304
P356
10.2217/PGS.10.50
P577
2010-06-01T00:00:00Z